Ladenburg Thalmann Expands Biotechnology Equity Research Team with Addition of Two Senior Analysts, Rick Bienkowski, Ph.D. and Caroline Palomeque
Ladenburg Thalmann & Co. Inc. (“Ladenburg Thalmann”), a middle-market investment bank providing investment banking, equity research, and institutional sales and trading services, and subsidiary of Osaic, Inc. (“Osaic”), today announced that Rick Bienkowski, Ph.D. and Caroline Palomeque have joined the firm’s Biotechnology Equity Research team as Managing Directors.
Ladenburg Thalmann Expands Investment Banking Platform with Biotechnology Specialist Dr. Aydin Huseynov, M.D., CFA
Ladenburg Thalmann & Co. Inc. (“Ladenburg Thalmann”), a leading middle-market investment bank providing investment banking, equity research, and institutional sales and trading services, today announced that Aydin Huseynov, M.D., CFA, has joined the firm's Healthcare Investment Banking Group as Managing Director, Biotechnology Investment Banking Specialist.
